Novartis
FDA Approves Alpelisib, First PI3K Inhibitor for Breast Cancer
Piqray, used with Faslodex, is indicated for postmenopausal women, and men, with HR-positive, HER2-negative, ...
MAY 29, 2019
FDA Approves Oral Drug for Relapsing Forms of MS
Mayzent is the first and only treatment specifically approved for patients with active secondary progressive ...
MARCH 27, 2019
Secukinumab Rx Improves Quality-of-Life Measurements as Early as 4 Weeks
Findings suggest that helping patients feel better through improved quality of life and ability to function ...
JANUARY 28, 2019
Sandoz, Novartis Recall Prescription Drug Blister Packs That Fail Child Safety Closures
The pharmaceutical companies Sandoz and Novartis issued a voluntary recall of prescription drug blister packages ...
JULY 9, 2018
A ‘Paradigm Shift’ for Migraine Prevention
Las Vegas—The FDA approval of erenumab-aooe (Aimovig, Amgen/Novartis) presents a “paradigm shift” ...
JUNE 12, 2018
Aimovig Gets FDA Nod for Migraine Prevention
Aimovig is the first FDA-approved treatment to block the calcitonin gene–related peptide receptor, which ...
MAY 18, 2018
Generics May Not Mean Big Savings in Specialty
It usually takes more than one generic in a specialty marketplace to drive down prices, experts said.
MAY 9, 2018
Tasigna Receives Indication for Children With Rare Leukemia
The FDA granted an expanded indication for nilotinib to include treatment of first- and second-line pediatric ...
MARCH 22, 2018
Hospitals Take Lead Role In Newest Gene Cancer Rx
Two revolutionary new cancer therapies that use genetic engineering to treat ALL and certain types of lymphoma are ...
DECEMBER 2, 2017
FDA Approves Kymriah, First Gene Therapy in U.S.
CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia.
AUGUST 31, 2017
Tafinlar + Mekinist, Companion Dx Approved for BRAF V600E–Mutant Metastatic NSCLC
Dabrafenib (Tafinlar, Novartis) in combination with trametinib (Mekinist, Novartis) with Oncomine Dx Target Test ...
JUNE 23, 2017
FDA Approves Kisqali Femara Co-Pack
The co-pack is the first, and only currently available, combination pack with two prescription products for ...
MAY 10, 2017
